Unraveling the plethora of toxicological implications of nanoparticles on living organisms and recent insights into different remediation strategies: A comprehensive review.

Increased use of nanoscale particles have benefited many industries, including medicine, electronics, and environmental cleaning. These particles provide higher material performance, greater reactivity, and improved drug delivery. However, the main concern is the generation of nanowastes that can spread in different environmental matrices, posing threat to our environment and human health.

Microplastics as an emerging menace to environment: Insights into their uptake, prevalence, fate, and sustainable solutions.

The inflated demand for plastic products has led to tremendous rise in plastic debris in different environmental matrices, thereby resulting in plastic pollution. This affects plants, animals, and even humans, as microplastics can enter the food chain and cause several health implications. Microplastics are the small plastic particles (size below 5 mm) that are largely debated nowadays owing to their environmental risk assessment.

Sulphadoxine-pyrimethamine plus azithromycin may improve birth outcomes through impacts on inflammation and placental angiogenesis independent of malarial infection.

Intermittent preventive treatment with sulphadoxine-pyrimethamine (SP) and SP plus azithromycin (SPAZ) reduces low birthweight (<2,500 g) in women without malarial and reproductive tract infections. This study investigates the impact of SPAZ on associations between plasma biomarkers of inflammation and angiogenesis and adverse pregnancy outcomes in 2,012 Papua New Guinean women. Concentrations of C-reactive protein (CRP), α-1-acid glycoprotein (AGP), soluble endoglin (sEng), soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) were measured at enrolment and delivery in a trial comparing SPAZ to SP plus chloroquine (SPCQ).